Cargando...
Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
Younger patients with COVID-19 may experience an exaggerated immune response to SARS-CoV-2 infection and develop cytokine release syndrome (CRS), which may be life threatening. There is no proven antiviral therapy for COVID-19 so far, but profound immunosuppression has recently been suggested as a t...
Gardado en:
| Publicado en: | Eur J Case Rep Intern Med |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SMC Media Srl
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213824/ https://ncbi.nlm.nih.gov/pubmed/32399455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001675 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|